ClinicalTrials.gg
CompletedNCT02107001UPPUpdated Dec 2, 2015

Lung Ultrasound in Pleuritic Chest Pain

An observational study in Community Acquired Pneumonia, Pleuritis and Pulmonary Embolism, sponsored by University of Milan. Completed at 7 sites in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-12-02.

Sponsored by University of Milan · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Community-Acquired Pneumonia with a site in Italy — 6 open to participants now, 6 under way, 2 of them phase 3. Community-Acquired Pneumonia · Italy.

Planned enrollment
7th of 11
400 · median 500
Started
2014
the only one that year
Observational
11 of 17
4 open now
Registered
7th of 17
by date
Lead sponsor
4 of 17
University of Milan

Among the 17 studies in Community-Acquired Pneumonia with a site in Italy, this one is the 7th largest by planned enrollment of the 11 observational ones that give a count, is the only one that started in 2014, is one of 11 observational ones, and was the 7th registered.

Community-Acquired Pneumonia

325 studies on the registry are indexed under Community-Acquired Pneumonia; 77 are open to participants now.

Browse Community-Acquired Pneumonia studies →

Open to participants now

6 of the 17 studies in Community-Acquired Pneumonia with a site in Italy are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 41 Community-Acquired Pneumonia studies recruiting now, 29 (71%) set no upper age limit and 9 (22%) stop at 75 or younger; 13 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Community-Acquired Pneumonia with a site in Italy, or all of them as a file.
02

Study summary

Chest pain is an alarming symptom and one of the most frequent causes of access to the Emergency Departement. Although chest X-ray remains an essential step in the diagnostic process, several studies showed numerous limitations of radiography which frequently is inconclusive. Ultrasonography is a non-radiating imaging technique. Albeit a wide use of ultrasound, the utilization of ultrasound in the study of the lung has only recently been introduced in the clinical practice. Several studies proved that lung ultrasound is useful in the diagnosis of lung consolidation in community acquired pneumonia. Nowadays, ultrasound is not routinely used in the presence of chest pain. Our hypothesis based on clinical experience is that, in patients with pleuritic chest pain, lung ultrasound is very sensitive in detecting pneumonia and other lung diseases (such as pneumothorax) thus performing better than radiography. The primary aim of this study is to verify, in patients affected by pleuritic chest pain, the accuracy of lung ultrasound compared to chest-X-ray. The secondary aim is to evaluate the accuracy of lung ultrasound consolidations in distinguishing lung consolidation in pneumonia, atelectasis, pulmonary infarction, or tumors.

03

Conditions studied

  • Community Acquired Pneumonia
  • Pleuritis
  • Pulmonary Embolism
  • Lung Cancer

Keywords

  • Lung ultrasound
  • Community acquired p neumonia (CAP)
  • Pleuritis
  • Pulmonary embolism
  • Lung Cancer
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Inpatients and outpatients presenting with pleuritic chest pain referred for medical consultation to italian university and clinical hospitals.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patient aged 18 years and older
  • patient affected by thoracic pleuritic pain

Exclusion criteria

Exclusion Criteria:

  • patient affected by a chronic condition causing thoracic pain
  • patient affected by acute cardiovascular diseases (e.g. acute coronary syndrome)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with pleuritic chest pain

    Study investigators will perform lung ultrasound in each patient with pleuritic chest pain at inclusion

    Procedure: Lung ultrasound

Interventions

  • ProcedureLung ultrasound

    Lung ultrasonography performed and interpreted by a physician (Pulmonologist or Emergency Physician) possessing specific knowledge in the procedure and a training of at least 100 thoracic ultrasonographies in accordance to a prespecified protocol.

    Also known as: Lung sonography

06

What researchers measure

Primary outcomes

  1. Sensitivity and specificity of lung ultrasound in pneumonia, chest wall pain, lung cancer, pulmonary embolism or other causes in patients presenting with pleuritic chest pain.

    Sensitivity and specificity, positive and negative predictive values of lung ultrasound in pneumonia, chest wall pain, lung cancer, pulmonary embolism or other causes in patients presenting with pleuritic chest pain.

    Time frame: 30 days

Secondary outcomes

  1. Accuracy of ultrasound in distinguishing lung consolidation in pneumonia, atelectasis, pulmonary infarction or tumors

    Accuracy of ultrasound in differentiating consolidation in distinguishing lung consolidation in pneumonia, atelectasis, pulmonary infarction, tumors or other diseases with respect to the final diagnosis stated by a scientific committee.

    Time frame: 30 days

07

Study locations

7 sites
  • Emergency Department, Azienda Ospedaliera Universitaria Careggi, Firenze.
    Florence, Italy
  • USC Pneumologia, Azienda Ospedaliera della Provincia di Lodi
    Lodi, Italy
  • - U.O.C Broncopneumologia, IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano.
    Milan, Italy
  • Emergency Department, San Paolo Hospital
    Milan, Italy
  • Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano.
    Milan, Italy
  • S.O.C. Pneumologia, Ospedale S. Luca, Rovigo.
    Rovigo, Italy
  • - Dipartimento di Medicina d'Urgenza, Ospedale Universitario, S. Luigi Gonzaga, Orbassano (TO).
    Turin, Italy
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2014, a primary completion of Nov 2015 and a completion of Nov 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2014
First posted
Apr 8, 2014
Start
Mar 2014
Primary completionActual
Nov 2015
CompletionActual
Nov 2015
Last update
Dec 2, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02107001
Responsible party
Fabiano Di Marco (M.D., Ph.D., University of Milan) — Principal investigator
First posted
Apr 8, 2014
Start date
Mar 2014
Primary completion
Nov 2015
Completion
Nov 2015
Last update
Dec 2, 2015

Study contacts

Giuseppe Francesco Sferrazza Papa, M.D.
principal investigator · Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano, Milan, Italy.
Stefano Centanni, M.D, Ph.D.
study chair · Respiratory Unit, San Paolo Hospital, Dipartimento Scienze della Salute, Università degli Studi di Milano, Milan, Italy.
Giovanni Volpicelli, M.D.
study director · Emergency Medicine staff Physician San Luigi Gonzaga University Hospital Torino, Italy.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion